Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
A privately held biotechnology company based in the Boston, Massachusetts area. It operates as an enabling platform business ...
La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...
With the rapid development of industrialization, large amounts of toxic and harmful gases such as NO2, CO, and NH3 are emitted during industrial ...
Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.
The latest update on Ginkgo Bioworks Holdings has reset its fair value anchor from US$12.00 to US$10.00, reflecting a more ...
New investors include Pfizer Ventures and Apricot Capital with proceeds to advance pipeline and global expansionVibrant’s ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results